z-logo
Premium
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
Author(s) -
Puoti C,
Magrini A,
Stati T,
Rigato P,
Montagnese F,
Rossi P,
Aldegheri L,
Resta S
Publication year - 1997
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.510260603
Subject(s) - asymptomatic , alanine transaminase , medicine , gastroenterology , elevated transaminases , genotype , hepatitis c virus , viral load , alanine aminotransferase , viral hepatitis , liver disease , transaminase , viral disease , virus , immunology , biology , biochemistry , gene , enzyme
This study was aimed to evaluate demographic, clinical, histological, and virological characteristics of 46 hepatitis C virus (HCV) carriers with persistently normal alanine transaminase (ALT) levels and to compare the results with those obtained in a group of 52 HCV‐RNA‐positive patients with elevated ALT levels. Subjects with normal ALT were more often females ( P < .001), were more likely to be asymptomatic ( P < .001), and have a lower incidence of risk factors for HCV transmission ( P < .01). All patients with normal ALT had significant histological liver damage. The mean grading and staging did not differ between patients with normal and those with raised ALT concentrations. Moderate to severe hepatitis was more frequently found among subjects with normal than with elevated ALT. HCV genotype 2a was far more common in subjects with normal (43%) than with abnormal ALT levels (6%; P < .002), genotype 1b being more frequent in these latter (50% vs. 17%; P < .001). Patients with normal ALT levels had similar serum HCV‐RNA titers than subjects with raised ALT. Neither HCV genotype distribution nor viral load correlated with the severity of liver damage. We conclude that significant liver disease may occur irrespective of clinical symptoms, ALT levels, HCV genotypes, and viral load.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here